This activity is intended for neurologists, critical care clinicians, internists, pediatricians, nurses, physician assistants, pharmacists, hospice and palliative medicine clinicians, and other members of the health care team involved in neurologic palliative care.
The goal of this activity is for learners to be better able to describe new expert guidance on palliative care for patients with neurologic disorders, based on a position statement developed by a joint committee of the American Academy of Neurology, American Neurological Association, and Child Neurology Society.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Medscape, LLC designates this enduring material for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0 contact hours are in the area of pharmacology.
Medscape designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number: JA0007105-0000-22-104-H01-P).
Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until 4/29/2023. PAs should only claim credit commensurate with the extent of their participation.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of
continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the
time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the
valid credit period that
is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in
your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as
the certificates from the
CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 4/29/2022
Valid for credit through: 4/29/2023
processing....
Palliative care includes much more than hospice services, lead author of the new position statement Lynne P. Taylor, MD, from the University of Washington, Seattle, and a fellow of the AAN, said in a press release. "Neurologists provide palliative care to people living with life-altering neurologic illnesses not just at the end of life but throughout the course of a disease, improving their lives with symptom control," she added.
Palliative care improves quality of life for patients and families with life-changing illness by preventing and managing physical, psychosocial, and spiritual suffering. All clinicians provide primary palliative care; interprofessional teams provide specialty palliative care.
The American Academy of Neurology (AAN) has released new expert guidance on palliative care for patients with stroke, dementia, Parkinson's disease, and other neurologic disorders. This position statement replaces 3 others regarding supportive care for patients with unique disorders of consciousness: persistent vegetive state, those who are irreve4rsibly paralyzed but retain cognition, and those who lack decisional capacity.
The position paper, developed by a joint committee of the AAN, American Neurological Association, and Child Neurology Society, was published online March 8 in Neurology.
Guidance Across the Life SpanThe new paper, an update of previous position statements, includes palliative care guidance for different neurologic disorders across the life span.
For example, neuropalliative care for neonates deserves "extra consideration" because one third of pediatric deaths occur during the neonatal period, most often in the neonatal intensive care unit and after withdrawal of life-sustaining interventions, the investigators note.
For older children, neuropalliative care consultation benefits families trying to maximize the quality of the remainder of their child's life. Decision-making must consider the child's cognitive abilities, the diagnosis, the perceived level of suffering, parental values, and the family's understanding of the prognosis, the authors note.
Also important is engaging in shared decision-making with patients and families.
"This approach requires the physician to elicit a patient's goals, make recommendations based on whether medical treatments are likely to achieve those goals, and work with patients and families to finalize a treatment plan," the new guidance notes.
Ethical ConsiderationsWhen treatments are physiologically futile, clinicians need to explain why interventions that may cause harm and have no benefit are not offered.
The authors cite cardiopulmonary resuscitation in the setting of cardiac arrest from irreversible herniation as an example of futility in the context of neurologic disease.
When life-prolonging care is no longer an option, clinicians have an obligation to shift the focus of care to preserving quality of life and comfort as much as possible, they add.
The investigators also broached ethical considerations for individual neurologic conditions. Concerns for disorders of consciousness include misdiagnosis or inaccurate prognostication, and serial examinations are needed to reevaluate levels of cognition, psychological state, decision-making capacity, and disease trajectory.
Stroke, Dementia, Parkinson's GuidanceFor stroke, the guidance suggests that neurologists encourage patients with retained decision-making capacity to complete advance care planning, given the risk for recurrent stroke and loss of capacity in the future.
For dementia, a proper and timely diagnosis can help patients and their families prepare for the consequences of cognitive dysfunction and loss of autonomy while respecting their identified values, the authors write.
They note that for Parkinson's disease, which is marked by slow functional and cognitive decline, neurologists must aim to anticipate and treat symptoms, address psychosocial and spiritual distress and caregiver burden, and engage patients and families in advance care planning before onset of cognitive impairment.
It is also important to anticipate patient preferences for future disability-specific decisions, such as those related to feeding tubes and mechanical ventilation, and to identify the patient's minimal acceptable outcome from these life-sustaining interventions.
Well-Timed UpdateCommenting for Medscape Medical News, Kate T. Brizzi, MD, a Boston, Massachusetts, neurologist with experience in hospice and palliative care, said that the updated position statement is "well-timed," as neuropalliative care has evolved dramatically during the last decade.
"In the last several years, I've witnessed a significant increase in trainee interest in the field, and there is growing recognition of how a palliative care approach can improve patient care, and hopefully outcomes," said Dr Brizzi.
Dr Brizzi noted that communication tools that help facilitate discussions around shared decision-making "have enhanced our ability to meet the palliative care needs of our patients and can be incorporated by any provider."
There was no targeted funding for this paper. One coauthor reported participation on member adjudication committees for clinical trials for Novo Nordisk, Sunovion, and Galapagos. The remaining authors have disclosed no relevant financial relationships.
Neurology. 2022;98:409-416.[1]